Stay updated on Nivolumab+Radiation±Ipilimumab in NSCLC Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the Nivolumab+Radiation±Ipilimumab in NSCLC Brain Metastases Clinical Trial page.

Latest updates to the Nivolumab+Radiation±Ipilimumab in NSCLC Brain Metastases Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page revision tag has been updated from v3.6.2 to v3.6.3, indicating a minor editorial or formatting update. It does not reflect substantive changes to the study information on the page.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.2, indicating a newer build of the page with potential minor backend or presentation updates rather than substantive content changes.SummaryDifference0.0%

- Check33 days agoChange DetectedThe page now reflects that recruitment has ended and adds new help/navigation sections to assist users in understanding and joining studies. A new Revision: v3.6.0 tag appears, signaling an updated page version.SummaryDifference0.4%

- Check41 days agoChange DetectedThe page displays a new revision label, updating from Revision: v3.5.4 to Revision: v3.5.5, signaling an administrative update to the study record.SummaryDifference0.0%

- Check55 days agoChange DetectedThe study record's update dates were refreshed to 2026 dates (e.g., 2026-05-20 and 2026-05-18), with older 2025 timestamps removed, indicating ongoing maintenance of the record.SummaryDifference0.2%

- Check62 days agoChange DetectedA new revision tag was introduced: Revision: v3.5.4, replacing Revision: v3.5.3. This signals a minor update to the page release and does not modify the study content or data shown on the record.SummaryDifference0.0%

Stay in the know with updates to Nivolumab+Radiation±Ipilimumab in NSCLC Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab+Radiation±Ipilimumab in NSCLC Brain Metastases Clinical Trial page.